Patents by Inventor Carmen Ruiz Velasco

Carmen Ruiz Velasco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR)
    Publication number: 20240125700
    Abstract: A system for identification of a biological structure present in a liquid biopsy sample is provided. The system identifies common biological structures and rare biological structures based on their fluorescence characteristics and morphology. The identified biological structures may be used in diagnosis and treatment of a human afflicted with a disease. Examples described in this disclosure also relate to methods and assays that may be used together with the systems of this disclosure for diagnosis and treatment of a human afflicted with a disease.
    Type: Application
    Filed: October 14, 2020
    Publication date: April 18, 2024
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Peter KUHN, Carmen RUIZ VELASCO, Shoujie CHAI, James HICKS, Anand Ratnakar KOLATKAR, Nicholas MATSUMOTO, Rafael NEVAREZ, Benjamin ORMSETH
  • Anti-metastatic marine bacterial exopolysaccharide derivative and uses thereof
    Patent number: 11219638
    Abstract: The invention provides a low-molecular-weight (15 kDa) over-sulfated exopolysaccharide (GYS15) prepared from a marine native exopolysaccharide excreted by a mesophilic marine bacterium from a deep-sea hydrothermal environment, and relates to the use of this low-molecular-weight over-sulfated exopolysaccharide for the prevention or inhibition of metastases formation.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: January 11, 2022
    Assignees: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER), UNIVERSITE DE NANTES, INSERM (Institut National de la Santé et de la Recherche Médicale), CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
    Inventors: Sylvia Colliec-Jouault, Corinne Sinquin, Jacqueline Ratiskol, Dominique Heymann, Carmen Ruiz-Velasco, Julie Chesneau
  • COMPOSITIONS AND METHODS FOR FLUID BIOPSY OF MELANOMA
    Publication number: 20210396757
    Abstract: The present invention provides methods for identifying circulating melanoma cells (CMCs) in a biological sample and methods for diagnosing metastatic melanoma in a subject. The methods disclosed can be used on non-enriched blood samples to identify CMC using detectable agents that are specific for a biomarker of CMCs and assessing the morphology of the cells having the detectable agents. The presence or absence of a detectable agent in combination with morphological characteristics of the cells can be used diagnose a subject with metastatic melanoma based on the number of CMCs is present in the sample.
    Type: Application
    Filed: January 27, 2021
    Publication date: December 23, 2021
    Inventors: Peter Kuhn, Carmen Ruiz Velasco
  • AN ANTI-METASTATIC MARINE BACTERIAL EXOPOLYSACCHARIDE DERIVATIVE AND USES THEREOF
    Publication number: 20180280427
    Abstract: The invention provides a low-molecular-weight (15 kDa) over-sulfated exopolysaccharide (GYS15) prepared from a marine native exopolysaccharide excreted by a mesophilic marine bacterium from a deep-sea hydrothermal environment, and relates to the use of this low-molecular-weight over-sulfated exopolysaccharide for the prevention or inhibition of metastases formation.
    Type: Application
    Filed: September 28, 2016
    Publication date: October 4, 2018
    Inventors: Sylvia Colliec-Jouault, Corinne Sinquin, Jacqueline Ratiskol, Dominique Heymann, Carmen Ruiz-Velasco, Julie Chesneau
  • COMPOSITIONS AND METHODS FOR FLUID BIOPSY OF MELANOMA
    Publication number: 20170192003
    Abstract: The present invention provides methods for identifying circulating melanoma cells (CMCs) in a biological sample and methods for diagnosing metastatic melanoma in a subject. The methods disclosed can be used on non-enriched blood samples to identify CMC using detectable agents that are specific for a biomarker of CMCs and assessing the morphology of the cells having the detectable agents. The presence or absence of a detectable agent in combination with morphological characteristics of the cells can be used diagnose a subject with metastatic melanoma based on the number of CMCs is present in the sample.
    Type: Application
    Filed: May 8, 2015
    Publication date: July 6, 2017
    Inventors: Peter Kuhn, Carmen Ruiz Velasco